Emina Curic: Improving the Understanding of Factor V Leiden in Everyday Clinical Practice
Emina Curic, Master of Science in Pharmaceutical Science, Clinical pharmacology and PhD student at Center for Primary Healthcare Research, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Thrombosis and Thrombolysis, adding:
“I’m excited to share our latest publication:
Real-world data on Factor V Leiden in Sweden: A nationwide family study
This study highlights the value of real-world nationwide data in improving our understanding of Factor V Leiden in everyday clinical practice.
We found that Factor V Leiden is likely underdiagnosed in Sweden and is associated with a substantially increased risk of venous thromboembolism. I hope these findings will encourage further discussion on optimizing thrombophilia screening and risk assessment.
I’m grateful to all my co-authors and especially my supervisor, Professor Bengt Zöller who made this work possible.
It’s been a rewarding project, and I hope these findings contribute to improving evidence-based care for patients at risk of venous thromboembolism.”
Title: Real-world data on Factor V Leiden in Sweden: A nationwide family study
Authors: Emina Curic, MirNabi Pirouzifard, Kristina Sundquist, Bengt Zöller

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series